BiomeOS
The intelligence platform for your second nervous system: the thirty-seven trillion organisms governing mood, immunity and metabolism.
- Market
- $23B diagnostics → $2T consumer wellness
- Revenue model
- $200M–$800M
- State
- Concept
The organisms inside a healthy human body produce most of its serotonin, regulate immune response and speak to the brain through a direct neural pathway. You have no interface with them. BiomeOS integrates personalised microbiome profiling with nutrition, pharmaceutical interactions, environment, sleep and immune markers into a continuously updating model, then makes it actionable: which foods, supplements and conditions are measurably helping you, and which are quietly causing the fatigue, inflammation and fog.
Nine domains of human experience that are simultaneously among the largest economic markets in the world and the most comprehensively ignored by the startup ecosystem. In each, the competitive landscape can be described in one word: empty.
The founding letters explain the whole architecture →